SENSEX NIFTY
FOCUS ON ECONOMY
  • Need near-term reforms urgently to boost eco growth: Biocon

    Kiran Mazumdar Shaw said economy needs some urgent boost. Government must come out with short-term m...

  • Mid-term review does not capture recent global events: ICAN

  • Mid-year eco review: FY15 can sign out with 5.5% growth

    India's economy is expected to grow at around 5.5% in the fiscal year to March 2015, the finance min...

  • 5.5% GDP can be achieved despite expense cuts: Pronab Sen

  • Sensex gains over 300 pts; Coal India up 3%, HUL drags

    Top multi bagger recommendations in 2014

    Did you invest in these stocks?

    Company Name Reco Date Reco Price Peak
    from Reco
    Gain %
    Alicon Castalloy Aug 20th 2014 152 334.50 119.49
    DCB Bank Aug 19th 2014 81 117.40 36.36
    RS Software (India) Aug 12th 2014 430 830.00 93.02
    Visaka Industries Jun 16th 2014 101 143.00 41.03
    IFGL Refractories May 28th 2014 114 218.25 91.11

    Stock Quote

    GET QUOTE

    Market Action

    SENSEX
     
    NIFTY
     
    DAX (Dec 19) 9856.91 45.85 0.47%
    CAC (Dec 19) 4273.65 24.16 0.57%
    FTSE (Dec 19) 6508.90 42.90 0.66%

    See all global markets »

    Gold - Feb 05 26,877.00 62.00 0.23%
    Silver - Mar 05 36,592.00 37.00 0.10%
    Naturalgas - Dec 26 230.20 -0.40 -0.17%
    Crudeoil - Jan 16 3,489.00 -78.00 -2.19%

    See all commodity prices »

    Dollar / Rupee 63.08 -0.03 -0.05%
    Euro / Rupee 77.46 0.08 0.11%
    Pound / Rupee 98.86 0.18 0.18%

    View all exchange rates »

    INDIAN HOTELS - 912458 115.80 1.70 1.49%
    INDIABULLS HSG - 961774 455.00 -3.20 -0.7%
    IRFC - N2 1,095.00 0.28 0.03%

    View all listed bonds »

    Mohit Gaba

    Technical Analyst ,
    (19 Dec- 15:30hrs)

    Ask Mohit Gaba

    Your Stocks, Our Advice! Send in your queries
    and get a chance to have them answered by
    our experts at CNBC-TV18

    Corporate Action

    Board Meetings
    Company Name
    Agenda
    To Consider Allotment of Equity Shares
    Allotment of the Equity Shares
    Others
    AGM / EGMs
    Bonus
    Splits
    Rights
    Dividend
    by
    COMPANY NAME
    Last Price
    Change
    MARKET CAP
    Net SAles
    Net Profit
    Assets
    2514.65
    53.95
    492,551.53
    64672.93
    18474.92
    39,230.48
    351.00
    6.05
    300,297.70
    83890.27
    22094.81
    123,653.60
    371.50
    -3.35
    296,666.96
    33238.60
    8785.21
    25,293.47
    900.85
    20.75
    291,431.28
    390117.00
    21984.00
    282,106.00
    377.55
    10.00
    238,474.34
    314.25
    15008.54
    15,907.79
    Result Screener
    Valuation Statistics
    My TV CNBC TV18 CNBC Awaaz
    Broker Research
    • HSIL

      369.00 0.96%

      Firstcall Research

    • Kolte-Patil

      188.10 -0.42%

      Emkay Global Financial Services

    • Glenmark

      747.00 1.78%

      Firstcall Research

    • Amara Raja Batt

      790.10 4.3%

      Emkay Global Financial Services

    • Bank of India

      288.90 -0.87%

      Way2Wealth

    • Titan Company

      376.15 -0.32%

      Emkay Global Financial Services

    • Union Bank

      223.40 0.45%

      ICICIdirect.com

    • Shilpa

      624.00 1.59%

      Firstcall Research

    • Orbit Exports

      386.25 -0.92%

      Firstcall Research

    • Hero Motocorp

      3116.00 1.6%

      Emkay Global Financial Services

    NEWS FLASH

    • Astec Life : To Issue Shrs Up To Rs 10 Cr Via Pref Allotment At Rs 108/Sh
    • Astec Life : Bd OKs Issue Of Shrs Worth Up To Rs 10 Cr To Non-promoter Grp
    • HOUSE VIEWS Macquarie On Accenture : Results +ve for IT sector post muted TCS commentary
    • HOUSE VIEWS Macquarie On Accenture : Increase in outlook is positive for demand environ
    • HOUSE VIEWS Macquarie On Accenture : Guidance beating results is positive for demand environ
    • HOUSE VIEWS CLSA On Accenture : Reiterate outperform,raise tgt price to $100/sh from $90/sh
    • HOUSE VIEWS Macquarie On Biocon : Reinitiate coverage with tgt at Rs 451/sh & underperform rtg
    • HOUSE VIEWS Macquarie On Biocon : Capacity constraints to impact growth over medium-term
    • HOUSE VIEWS Macquarie On Biocon : R&D initiatives to realise upsides only beyond 2017
    • HOUSE VIEWS Macquarie On Biocon : Few triggers for valuation gap to narrow w/peers in near-term
    • HOUSE VIEWS Macquarie On Biocon : Syngene listing to be a key newsflow to watch for

    Now Playing

    YOUR STOCKS

    Interact with CNBC-TV18

    Post Your Query

    Your Stocks

    Send in your queries and have them answered by our experts at CNBC-TV18

    Your Details

    Market Masters

    Send in your queries and have them answered by our experts at CNBC-TV18

    Your Details

    Your Opinion Matters

     

    3 days left in winter session; Should PM make a statement to break the deadlock? 84 comments

    Civil Aviation Ministry mulls a minimum & Maximum air fare. Should Govt regulate fares? 35 comments

    RS deadlock continues; Will Coal, Insurance bills fail the Winter test? 14 comments

    Markets rebound on Fed`s `patient` cue. Correction over? 13 comments

      What's your opinion?
    Explore Moneycontrol

    Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.